Dermapharm Holding SE (VIE:DMP)

Revenue by Product

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Branded Medicine	585.06M
Branded Medicine Growth	9.80%
Other Health Products	354.37M
Other Health Products Growth	-4.66%
Parallel Import	241.34M
Parallel Import Growth	4.56%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Germany	725.56M
Germany Growth	2.63%
France	139.10M
France Growth	-8.27%
Spain	117.57M
Spain Growth	-0.73%
Austria / Switzerland	94.86M
Austria / Switzerland Growth	38.34%
Other	103.68M
Other Growth	15.52%